Implementation and relevance of FAIR data principles in biopharmaceutical R&D.

Biological Products Biomedical Research Data Management Drug Industry

Journal

Drug discovery today
ISSN: 1878-5832
Titre abrégé: Drug Discov Today
Pays: England
ID NLM: 9604391

Informations de publication

Date de publication:
04 2019
Historique:
received: 20 10 2018
revised: 21 12 2018
accepted: 20 01 2019
pubmed: 29 1 2019
medline: 18 1 2020
entrez: 29 1 2019
Statut: ppublish

Résumé

Biopharmaceutical industry R&D, and indeed other life sciences R&D such as biomedical, environmental, agricultural and food production, is becoming increasingly data-driven and can significantly improve its efficiency and effectiveness by implementing the FAIR (findable, accessible, interoperable, reusable) guiding principles for scientific data management and stewardship. By so doing, the plethora of new and powerful analytical tools such as artificial intelligence and machine learning will be able, automatically and at scale, to access the data from which they learn, and on which they thrive. FAIR is a fundamental enabler for digital transformation.

Identifiants

DOI: 10.1016/j.drudis.2019.01.008 PMID: 30690198
pubmed: 30690198
pii: S1359-6446(18)30303-9
doi: 10.1016/j.drudis.2019.01.008
pii:
doi:

Substances chimiques

Biological Products 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

933-938

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

John Wise (J)

Pistoia Alliance, USA. Electronic address: john.wise@pistoiaalliance.org.

Alexandra Grebe de Barron (AG)

Bayer, Germany.

Andrea Splendiani (A)

Novartis, Switzerland.

Beeta Balali-Mood (B)

Pistoia Alliance, USA.

Drashtti Vasant (D)

Bayer, Germany.

Eric Little (E)

OSTHUS, USA.

Gaspare Mellino (G)

F. Hoffmann-LaRoche, Switzerland.

Ian Harrow (I)

Pistoia Alliance, USA.

Ian Smith (I)

MSD, UK.

Jan Taubert (J)

KWS SAAT SE, Germany.

Kees van Bochove (K)

The Hyve, The Netherlands.

Martin Romacker (M)

F. Hoffmann-LaRoche, Switzerland.

Peter Walgemoed (P)

Carelliance, The Netherlands.

Rafael C Jimenez (RC)

Elixir, UK.

Rainer Winnenburg (R)

Abbvie, Germany.

Tom Plasterer (T)

AstraZeneca, USA.

Vibhor Gupta (V)

PangaeaData.AI, UK.

Victoria Hedley (V)

Newcastle University Institute of Genetic Medicine, UK.

Articles similaires

COBRE Center for Stress, Trauma, and Resilience (STAR COBRE): A Regional and National Hub for Transformative Research to Elucidate and Mitigate the Lasting Imprint of Early Stress and Trauma.

Milagros Grados, Chrystal Vergara-Lopez, Beth C Bock et al.
1.00
Humans Resilience, Psychological Rhode Island Biomedical Research Stress, Psychological

Frequency of limitations statements in original research articles of United States leading medical journals: A meta-research protocol.

Nin-Chieh Hsu, Hung-Bin Tsai, Chia-Hao Hsu et al.
1.00
United States Periodicals as Topic Cross-Sectional Studies Humans Biomedical Research

Using Bayh-Dole Act March-In Rights to Lower US Drug Prices.

Lisa Larrimore Ouellette, Bhaven N Sampat
1.00
United States Cross-Sectional Studies Patents as Topic Humans Drugs, Generic

Development and Evaluation of Project Management Training for Cancer Research in Sub-Saharan Africa.

Elima Jedy-Agba, Caroline Andrews, Emeka Odiaka et al.
1.00
Humans Africa South of the Sahara Neoplasms Biomedical Research Male

Classifications MeSH

questionsmedicales.fr › Mélanges complexes › Produits biologiques › Implementation and relevance of FAIR data...
questionsmedicales.fr › Disciplines des sciences naturelles › Science › Recherche › Recherche biomédicale › Implementation and relevance of FAIR data...
questionsmedicales.fr › Sciences de l'information › Mémorisation et recherche des informations › Gestion des données › Implementation and relevance of FAIR data...
questionsmedicales.fr › Technologie, industrie et agriculture › Industrie › Secteur secondaire › Industrie pharmaceutique › Implementation and relevance of FAIR data...